Purified anti-mouse CD273 B7-DC, PD-L2 Antibody anti-CD273 - TY25,BioLegend,107202

Additional reported applications (for the relevant formats) include: immunoprecipitation1, Western blotting1,6, blocking2,4,5of PD-1 mediated interactions, and immunohistochemistry of acetone-fixed frozen sections3. The Ultra-LEAF™ purified antibody (Endotoxin < 0.01 EU/µg, Azide-Free, 0.2 µm filtered) is recommended for functional assays (Cat. Nos. 107221-107226).

Host

Rat

Reactivity

Mouse

Application

FC -Quality testedIHC-F, IP, WB -Reported in the literature, not verified in house

Platform ID

BAB910387386

BioLegend

Headquarters

8999 BioLegend Way San Diego, CA 92121 United States

Contact

Tel: 1-858-455-9588
Fax: +49 (4131) 7023913

Email:

Product Specifications
Scientific Background

Specifications

NamePurified anti-mouse CD273 B7-DC, PD-L2 Antibody anti-CD273 - TY25
Cat. No.107202
HostRat
RRIDAB_345250 (BioLegend Cat. No. 107202)
IsotypeRat IgG2a, κ
ReactivityMouse
ApplicationFC -Quality testedIHC-F, IP, WB -Reported in the literature, not verified in house
ClonalityMonoclonal
Clone NumberTY25
Concentration0.5 mg/ml
TargetCD273
ImmunogenMouse B7-DC transfected cell line
PurityThe antibody was purified by affinity chromatography.
FormulationPhosphate-buffered solution, pH 7.2, containing 0.09% sodium azide.
StorageThe antibody solution should be stored undiluted between 2°C and 8°C.
Regulatory StatusResearch Use Only

Scientific Background

B7-DC is also called programmed death ligand 2 (PDL2). It has recently been clustered as CD273. This ligand is a 42 kD member of the immunoglobulin receptor superfamily expressed on a subset of dendritic cells, liver and a small subset of macrophages as well as a few transformed cell lines. CD273 has been reported to be stimulatory on dendritic cells when cross-linked and to inhibit T cell activation upon engaging the PD-1 receptor. CD273 has also been reported to bind to an alternative receptor and to mediate T cell activation through such non-PD1 mediated interactions. The TY25 antibody has been reported to be useful for blocking PD-1 mediated interactions.

Category Paths

Request a product

Please provide the required information below so that we can quickly source your products.